Search Results for: APP

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
E2F8 E2F transcription factor 8
  • TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
EAF1 ELL associated factor 1
  • Formation of RNA Pol II elongation complex
  • RNA Polymerase II Pre-transcription Events
  • RNA Polymerase II Transcription Elongation
EBF4 EBF family member 4
EBP EBP cholestenol delta-isomerase
  • Cholesterol biosynthesis via desmosterol
  • Cholesterol biosynthesis via lathosterol
  • Tamoxifen
ECH1 enoyl-CoA hydratase 1
  • Peroxisomal protein import
  • Peroxisomal protein import
  • Mitochondrial protein degradation
ECHDC1 ethylmalonyl-CoA decarboxylase 1
ECHDC2 enoyl-CoA hydratase domain containing 2
ECI1 enoyl-CoA delta isomerase 1
  • mitochondrial fatty acid beta-oxidation of unsaturated fatty acids
  • Mitochondrial protein degradation
  • Octanoyl-Coenzyme A
  • Benzamidine
ECI2 enoyl-CoA delta isomerase 2
  • Myristic acid
ECSIT ECSIT signaling integrator
  • MyD88:MAL(TIRAP) cascade initiated on plasma membrane
  • Complex I biogenesis
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • MyD88 cascade initiated on plasma membrane
EEF1B2 eukaryotic translation elongation factor 1 beta 2
  • Eukaryotic Translation Elongation
EEF1D eukaryotic translation elongation factor 1 delta
  • Eukaryotic Translation Elongation
EEPD1 endonuclease/exonuclease/phosphatase family domain containing 1
  • NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
EFHD2 EF-hand domain family member D2
  • RHOD GTPase cycle
EFS embryonal Fyn-associated substrate
EGFR epidermal growth factor receptor
  • Signaling by ERBB2
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Signaling by ERBB4
  • SHC1 events in ERBB2 signaling
  • SHC1 events in ERBB2 signaling
  • PLCG1 events in ERBB2 signaling
  • PIP3 activates AKT signaling
  • Signaling by EGFR
  • GRB2 events in EGFR signaling
  • GAB1 signalosome
  • SHC1 events in EGFR signaling
  • EGFR downregulation
  • GRB2 events in ERBB2 signaling
  • PI3K events in ERBB2 signaling
  • EGFR interacts with phospholipase C-gamma
  • EGFR Transactivation by Gastrin
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • Signal transduction by L1
  • Constitutive Signaling by EGFRvIII
  • Inhibition of Signaling by Overexpressed EGFR
  • RAF/MAP kinase cascade
  • ERBB2 Regulates Cell Motility
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • ERBB2 Activates PTK6 Signaling
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • PTK6 promotes HIF1A stabilization
  • Downregulation of ERBB2 signaling
  • TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
  • Extra-nuclear estrogen signaling
  • NOTCH3 Activation and Transmission of Signal to the Nucleus
  • HCMV Early Events
  • Estrogen-dependent nuclear events downstream of ESR-membrane signaling
  • Signaling by ERBB2 KD Mutants
  • Signaling by ERBB2 ECD mutants
  • Signaling by ERBB2 TMD/JMD mutants
  • Respiratory syncytial virus (RSV) attachment and entry
  • Developmental Lineage of Mammary Gland Myoepithelial Cells
  • Cetuximab
  • Lidocaine
  • Gefitinib
  • Erlotinib
  • Lapatinib
  • Panitumumab
  • Alvocidib
  • IGN311
  • Matuzumab
  • Vandetanib
  • Rindopepimut
  • Canertinib
  • Pelitinib
  • Varlitinib
  • AV-412
  • S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE
  • PD-168393
  • Afatinib
  • Osimertinib
  • Necitumumab
  • Foreskin keratinocyte (neonatal)
  • Depatuxizumab mafodotin
  • Icotinib
  • Neratinib
  • Dacomitinib
  • Fostamatinib
  • Poziotinib
  • Zalutumumab
  • Brigatinib
  • Olmutinib
  • Zanubrutinib
  • Abivertinib
  • Mobocertinib
  • Almonertinib
  • Amivantamab
  • Laryngeal cancer
  • Cervical cancer
  • Oral cancer
  • Gastric cancer
  • Choriocarcinoma
  • Esophageal cancer
  • Glioma
  • Bladder cancer
EHF ETS homologous factor
EIF1 eukaryotic translation initiation factor 1
EIF1AX eukaryotic translation initiation factor 1A X-linked
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Translation initiation complex formation
  • Formation of a pool of free 40S subunits
  • Formation of the ternary complex, and subsequently, the 43S complex
  • Ribosomal scanning and start codon recognition
  • GTP hydrolysis and joining of the 60S ribosomal subunit
EIF2A eukaryotic translation initiation factor 2A

Page 28 out of 106 pages